Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1984-11-16
1986-04-15
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 49, 514222, A61K 3154, C07D27902
Patent
active
045828318
ABSTRACT:
A novel crystalline form of the monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide has been prepared. This novel crystalline form is designated as polymorph I and is useful in therapy as a non-steroidal anti-arthritic agent. Methods for preparing this polymorph from readily available materials are provided.
REFERENCES:
patent: 3591584 (1971-07-01), Lombardino
patent: 4434164 (1984-02-01), Lombardino
J. G. Lombardino et al., "Potent Antiinflammatory N-Heterocyclic 3-Carboxamides of 4-Hydroxy-2-Methyl-2H-1,-2H-1,2-2-Benzothiazine 1,1-Dioxide", Journal of Medicinal Chemistry, vol. 16, No. 5, p. 493, (1973).
Jiles Henry R.
Knuth Charles J.
Mullins J. G.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyri will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1439107